Who makes Prometa Treatment Program?

Prometa Treatment Program is developed by Institute of Addiction Medicine.

What development phase is Prometa Treatment Program in?

Prometa Treatment Program is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Prometa Treatment Program

Institute of Addiction Medicine · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Prometa Treatment Program
Sponsor	Institute of Addiction Medicine
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Women's Screening and Self-Testing Program (PROMETA) Study (NA)
Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Prometa Treatment Program CI brief — competitive landscape report
Prometa Treatment Program updates RSS · CI watch RSS
Institute of Addiction Medicine portfolio CI